Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 3/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CTSD | P07339 | 1/20 | 0.46 |
| ▸ | CFTR | P13569 | 1/20 | 0.46 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.45 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29453820 | 1.00 | KDM4E (0.53) | KDM4EPOLBATMGAAHSD17B10 | |
| SCHEMBL31031193 | 0.86 | HTT (0.54) | KDM4EHSD17B10TSHRMAPK1ALDH1A1 | |
| SCHEMBL12861288 | 0.86 | KCNK3 (0.49) | POLBGAAMAPTMAPK1LMNA | |
| SCHEMBL16599381 | 0.80 | POLB (0.55) | KDM4EPOLBATMHSD17B10MAPT | |
| SCHEMBL8203446 | 0.80 | LMNA (0.63) | KDM4EPOLBATMGAAHSD17B10 | |
| SCHEMBL27597208 | 0.80 | KDM4E (0.55) | KDM4EPOLBATMHSD17B10MAPT | |
| SCHEMBL18315876 | 0.79 | TSHR (0.56) | KDM4EPOLBATMGAAHSD17B10 | |
| SCHEMBL30605528 | 0.79 | MAPT (0.46) | KDM4EPOLBGAAHSD17B10MAPT | |
| Methyl 2-Methoxybenzoate SCHEMBL196037 | 0.79 | TSHR (0.69) | KDM4EPOLBATMGAAHSD17B10 | |
| Methyl 2-Methoxybenzoate SCHEMBL29702077 | 0.79 | TSHR (0.69) | KDM4EPOLBATMGAAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12161747-B2 | Gum and tooth treatment method with rinsing | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2024-12-10 | — | — | US | disclosed |
| US-20240390446-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES AND THYROID DISEASES | ALKALAY RACHEL (IL) | 2024-11-28 | — | — | US | disclosed |
| US-20240358626-A1 | GUM AND TOOTH TREATMENT METHOD WITH RINSING | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2024-10-31 | — | — | US | disclosed |
| US-12102708-B2 | Treatment method for teeth and gums | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2024-10-01 | — | — | US | disclosed |
| US-20240225996-A1 | TREATMENT METHOD FOR TEETH AND GUMS | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2024-07-11 | — | — | US | disclosed |
| US-20240226218-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING A CORONAVIRUS INFECTION | Novel Concepts Medical Ltd (IL) | 2024-07-11 | — | — | US | disclosed |
| US-12011496-B2 | Topical macqui berry formulation | Tracie Martyn International, Inc. (US) | 2024-06-18 | — | — | US | disclosed |
| US-11957782-B2 | Treatment method for teeth and gums | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2024-04-16 | — | — | US | disclosed |
| US-20230346866-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NON-MALIGNANT RESPIRATORY DISEASE | Novel Concepts Medical Ltd (IL) | 2023-11-02 | — | — | US | disclosed |
| US-20230346687-A1 | FLURIDE RELEASING TOOTHPASTE WITH ANTIBACTERIA AND BIOACTIVE PROPERTIES | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-11-02 | — | — | US | disclosed |
| CN-103288826-A | Alkaloid component in Nigella glandulifera Freyn seeds as well as preparation method and use thereof | XINJIANG TECH INST PHYSICS CAS | 2013-09-11 | — | — | CN | disclosed |
| CN-103285000-A | Use of alkaloid with framework types I and II in Nigella glandulifera Freyn seeds | XINJIANG TECH INST PHYSICS CAS | 2013-09-11 | — | — | CN | disclosed |
| CN-103102305-A | Alkaloid of skeleton type 2 in nigella glandulifera preyn and preparation method of alkaloid | XINJIANG TECH INST PHYSICS CAS | 2013-05-15 | — | — | CN | disclosed |
| CN-103086967-A | Alkaloid having type 1 skeleton in Nigellaglandulifera Freyn grass seeds, and its preparation method | XINJIANG TECH INST PHYSICS CAS | 2013-05-08 | — | — | CN | disclosed |
| US-20120114719-A1 | Topical Macqui Berry Formulation | TRACIE MARTYN INTERNATIONAL, LLC (US) | 2012-05-10 | — | — | US | disclosed |
| US-20100272790-A1 | Methods of Treating Skin | TRACIE MARTYN INTERNATIONAL, LLC (US) | 2010-10-28 | — | — | US | disclosed |
| US-7776915-B2 | Topical formulations and methods of use | TRACIE MARTYN INTERNATIONAL, LLC (US) | 2010-08-17 | — | — | US | disclosed |
| US-20070065396-A1 | Topical macqui berry formulation | TRACIE MARTYN INTERNATIONAL, LLC | 2007-03-22 | — | — | US | disclosed |
| US-20060216251-A1 | Topical formulations and methods of use | TRACIE MARTYN INTERNATIONAL, LLC (US) | 2006-09-28 | — | — | US | disclosed |
| CN-1784411-A | Fragrance compositions comprising benzo[4,5]thieno[3,2-b]pyran-2-one | FLEXITRAL INC (US) | 2006-06-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100272790-A1 | Methods of Treating Skin | CUTA, LIPA, DLAT | KDM4E 1602/4885POLB 1760/4885ATM 3020/4885 |
| US-20240390446-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES AND THYROID DISEASES | TPO, TNF, ADAMTS13 | KDM4E 4684/4885POLB 4693/4885ATM 3256/4885 |
| US-20060216251-A1 | Topical formulations and methods of use | CPT1B, SLC25A20, CPT1A | KDM4E 2265/4885POLB 1930/4885ATM 3176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.